Medpace is rated Sell, with a $484.49 fair value versus a $612.05 close—implying a 26.33% premium. Click to read more about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results